scorecardresearch
Add as a preferred source on Google
Tuesday, December 2, 2025
TopicCovid vaccines

Topic: Covid vaccines

Seed funding cancelled & the ghost of ‘Howdy Trump’

The best cartoons of the day, chosen by the editors at ThePrint.

In leg-up to vaccination, SII’s Covovax on CoWin as heterologous booster, to cost Rs 225

Amid rising infection, SII had sought the inclusion of Covovax as a heterologous booster on the CoWin web portal last week.

11% of 69 crore eligible people have taken Covid precaution dose, says govt, blames waning fear

Slight rise in precaution dose coverage after vaccines were made free but govt officials cite ‘Covid surge in many countries’ to emphasise need to increase uptake.

BA.2.75 — new Covid variant detected in India a mystery, but could ‘have immune-escape property’

This Omicron sub-lineage may have increased ability to infect people who’ve been infected before, or are vaccinated, according to some scientists. However, there's no govt data on this.

DCGI approval in, but here’s why you can’t choose Corbevax as your booster just yet

Corbevax was, over the weekend, approved for heterologous use as a Covid booster shot by apex drug regulator Drugs Controller General of India.

Our take on WHO’s Covid deaths estimate, RBI rate hike, SC’s vaccine take — in 50 words

ThePrint view on the most important issues this week.

2nd Covid shot from Serum Institute, Rs 225/dose: All about Covovax, new jab approved for teens

Covovax, developed by US company Novavax & manufactured in India by Serum Institute, is a protein-based vaccine developed from SARS-CoV-2 strain.

The ZyCoV-D mystery: 3 months after arrival in Bihar, not a single Covid vaccine shot given

Covid vaccine developed by Zydus Lifesciences was approved for use in those aged 12 and above in September 2021. Centre ordered 1 crore doses last year & delivery began in February.

We can’t ‘boost’ our way out of the Covid pandemic for the long term

While the vaccine is effective at preventing severe disease, it is likely that boosters will become an annual shot. Here's the science behind it.

New Covid vaccine developed in Germany produces better immune response in cancer patients

Peptide-based vaccine CoVac-1 has been developed by researchers at University of Tübingen. They say it induces better T-cell immune response in immunocompromised patients.

On Camera

RSS is warming up to Yogi Adityanath. CM has many more boxes to tick

It’s not just the Opposition parties Yogi Adityanath has to contend with. His detractors within the BJP are no less formidable.

Modi govt’s PM internship scheme saw high attrition in Year 1. Just 30% joined, 41% quit midway

According to government reply in Lok Sabha, the pilot phase of PMIS is being used to test concepts, strategies and systems before a full-scale implementation of the scheme.

After Op Sindoor, India goes in for more Heron Mk IIs; Israel frontrunner for mega MALE drones deal

Order for 87 MALE drones will be split between 2 Indian firms in 64:36 ratio to ensure there are 2 independent manufacturing lines with at least 60% indigenous components.

Gaali cricket: Bavuma stands tall, India’s Test ego cut to size

The India-South Africa series-defining fact is the catastrophic decline of Indian red ball cricket where a visiting team can mock us with the 'grovel' word.